About Biopticon
Biopticon is a company based in Princeton (United States) founded in 2003. Biopticon offers products and services including TumorImager 2 and TumorManager. Biopticon operates in a competitive market with competitors including NavVis, Impedimed, Rigaku, Speclipse and Anvajo, among others.
- Headquarter Princeton, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biopticon Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
NJEDA
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biopticon
Biopticon offers a comprehensive portfolio of products and services, including TumorImager 2 and TumorManager.
Provides fast and accurate 3D measurements of subcutaneous tumors in small animals.
Manages preclinical oncology studies from design to reporting and analysis.
Funding Insights of Biopticon
Investors in Biopticon
Biopticon has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NJEDA and RCTC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Economic development services are provided by NJEDA in New Jersey.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Biopticon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biopticon
Investment portfolio details for Biopticon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biopticon
Detailed financials for Biopticon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biopticon Comparisons
Peer comparison for Biopticon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biopticon
Biopticon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NavVis, Impedimed, Rigaku, Speclipse and Anvajo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital twin-powered indoor navigation solutions are developed for enterprises.
|
|
| Locked | Locked | Locked |
Technologies for non-invasive fluid status assessment and monitoring are developed.
|
|
| Locked | Locked | Locked |
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
|
|
| Locked | Locked | Locked |
Molecular spectroscopy systems for early skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Point-of-care solutions for laboratory diagnostics are provided by Anvajo.
|
|
| Locked | Locked | Locked |
3D cameras and scanners are provided for object capture.
|
Detailed competitors of Biopticon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biopticon
Complete news archive for Biopticon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biopticon
Biopticon was founded in 2003 and raised its 1st funding round 6 years after it was founded.
Biopticon is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Biopticon makes a hand-held imaging device that uses laser, photonics and image processing technologies to analyze subcutaneous tumors. The companys devices, TumorImager and TumorImager2, rapidly scan subcutaneous tumors (1 sec) without requiring the animal to be under anesthesia, providing highly sensitive, reproducible measurement of drug response. The instruments are meant for use on animals, especially for the study of subcutaneous xenograft tumors in rodents. Biopticon also makes a software product, TumorManager, which is a fully integrated platform that allows scientists to manage every aspect of subcutaneous xenograft studies from protocol design, randomization, dosing, data capture, graphics and statistical analysis. Customers include pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.
Biopticon's top competitors include NavVis, Revopoint 3D and Impedimed.
Biopticon offers TumorImager 2 and TumorManager.
Biopticon has 2 investors. Key investors include NJEDA, and RCTC.